No Data
No Data
No Data
No Data
No Data
LI, VERU and MRIN Among Pre-market Losers
Seeking AlphaApr 19 20:16
Veru, EyePoint Pharmaceuticals, SINTX Technologies Among Healthcare Movers
Seeking AlphaApr 18 22:00
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
BenzingaApr 16 02:11
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Farg
BenzingaApr 15 20:39
Oppenheimer Reiterates Outperform on Veru, Lowers Price Target to $5
Oppenheimer analyst Leland Gershell reiterates Veru with a Outperform and lowers the price target from $7 to $5.
Dow JonesApr 15 20:06
Oppenheimer: Reiterates the Veru (VERU.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $7.00 to $5.00.
Oppenheimer: Reiterates the Veru (VERU.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $7.00 to $5.00.
Zhitong FinanceApr 15 20:01
No Data
No Data